Noninvasive brain stimulation for the treatment of neurocognitive disorders: right for prime time?
Abstract
PURPOSE OF REVIEW: Neurocognitive disorders are associated with tremendous burden at the level of the individual, the care giver, and society at large. No effective treatments have been discovered to date.
RECENT FINDINGS: Noninvasive brain stimulation (NIBS) comprises several promising interventions that have been studied in Alzheimer’s disease and related dementias. Most recent studies have tested transcranial direct current stimulation or repetitive transcranial magnetic stimulation on their own or in combination with other interventions, particularly cognitive training. While most studies were proof-of-principle studies with small sample sizes, combination and long-duration protocols seem to be promising approaches to pursue. Some studies also investigated novel neurophysiological markers as predictors of response to NIBS.
SUMMARY: NIBS presents several interventional options that are ready to be evaluated using well powered, long-duration trials. These future studies should build on the promising leads from the current literature, including the potential advantage of combining NIBS with other interventions; the delivery of interventions for long durations to assess long-term impact; and the use of neurophysiological markers that could optimize the personalization and efficacy of NIBS.
PMID: 33395102 [PubMed – as supplied by publisher]
Curr Opin Psychiatry. 2020 Dec 31;Publish Ahead of Print:
Authors: Rajji TK
